Detalhe da pesquisa
1.
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
N Engl J Med
; 378(13): 1177-1188, 2018 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-29590544
2.
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
Lancet Oncol
; 21(12): 1620-1629, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33271092
3.
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(3): 398-411, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32014119
4.
Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme.
BMC Cancer
; 20(1): 91, 2020 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32013902
5.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29611518
6.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30420616
7.
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
Lancet Oncol
; 15(9): 1007-18, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24965569
8.
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.
Lancet Oncol
; 14(6): 481-9, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23594787
9.
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
J Clin Oncol
; : JCO2301326, 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38547438
10.
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS).
Clin Colorectal Cancer
; 22(2): 231-237, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36967267
11.
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
J Clin Oncol
; 41(4): 803-815, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36306483
12.
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.
Nat Med
; 29(3): 605-614, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36864254
13.
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
N Engl J Med
; 358(1): 36-46, 2008 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-18172173
14.
The Early Impact of the IDEA Collaboration Results: How the Results Changed Prescribing Practice.
JNCI Cancer Spectr
; 5(4)2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34350375
15.
Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices.
Cancer Treat Res Commun
; 28: 100445, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34425469
16.
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.
J Clin Oncol
; 39(36): 4009-4019, 2021 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34752136
17.
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors.
Clin Colorectal Cancer
; 20(4): 342-349, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34696965
18.
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer.
J Clin Oncol
; 39(6): 631-641, 2021 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33439695
19.
A new prognostic and predictive tool for shared decision making in stage III colon cancer.
Eur J Cancer
; 138: 182-188, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32892120
20.
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative.
Eur J Cancer
; 130: 63-71, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32172199